Cargando…
The results of aflibercept therapy as a first line treatment of age-related macular degeneration
PURPOSE: To report the results of aflibercept treatment in treatment-naive neovascular age-related macular degeneration (AMD) patients and suggest a suitable treatment algorithm for routine clinical practice. METHOD: The medical charts of patients treated with intravitreal aflibercept for neovascula...
Autores principales: | Unsal, Erkan, Cubuk, Mehmet Ozgur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407143/ https://www.ncbi.nlm.nih.gov/pubmed/30899849 http://dx.doi.org/10.1016/j.joco.2018.11.002 |
Ejemplares similares
-
The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab
por: Unsal, Erkan, et al.
Publicado: (2018) -
Aflibercept for the Treatment of Age-Related Macular Degeneration
por: Trichonas, George, et al.
Publicado: (2013) -
Preoperative prognostic factors for macular hole surgery: Which is better?
por: Unsal, Erkan, et al.
Publicado: (2019) -
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015) -
Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey
por: Yilmaz, Mevlut, et al.
Publicado: (2023)